Swiss Authorised Representative: All you need to Know
Since 26 May 2021, with the full application of the Medical Device Regulation MDR (EU) 2017/745 and in the absence of an institutional agreement reached, Switzerland is officially considered a “Third Country” for Europe.
This means that Swiss Manufacturers must appoint a European Authorised Representative to export their devices to Europe. At the same time, European Manufacturers must designate a Swiss Authorised Representative
and a Swiss Importer to export their products to Switzerland, in compliance with the Medical Device Ordinance (MedDo).
According to SR812.213 (MepV) Art. 104a from 01. July 2020 entering into force 26. May 2021 the following transition period for a manufacturer which is located in the EU or EER apply. They shall appoint a Swiss Repsentative for all produ ts placed on the Swiss market after 26. May 2021.
- December 31st, 2021: Class III and implantable class IIb and active implantable medical devices:
- March 31nd, 2022: Non-implantable products class IIb and IIa31.
- July 2022: Class I products, systems & procedure packs.